Coffee, caffeine, and cardiovascular health: navigating risks and benefits-an updated systematic review and meta-analysis
Shaban EE, Elmelliti H, Shaban A, Shaban A, Elkandow A, Abdelrahim MG, Zaki HA
BMC cardiovascular disorders · 0 citas
Cómo se estudió
- Diseño
- Metaanálisis (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Eventos clínicos como enfermedad o muerte
Quién lo pagó
- Financiación
- Financiación independiente
Según la declaración de financiación del texto completo.
Publicación
- Publicado
- 2026-05-07 · BMC Cardiovasc Disord · vol. 26 · número 1
- Editorial
- BioMed Central
- Citado
- 1 cita · más que el 90% de estudios similares · 3.0× el promedio de su campo
- Referencias
- 79 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY-NC-ND
- Áreas de investigación
- Coffee research and impacts · Alcohol Consumption and Health Effects · Tea Polyphenols and Effects
- Palabras clave
- Hazard ratio, Myocardial infarction, Stroke (engine), Odds ratio, Angiology, Caffeine, Cohort study, Epidemiology
- MeSH
- humans, cardiovascular diseases, caffeine, prognosis, risk assessment, risk factors, coffee, adult, aged, aged, 80 and over, middle aged, female, male, protective factors, heart disease risk factors
7 autores
- Eman E. Shaban
- Hussam Elmelliti🇶🇦 · autor de correspondenciaHamad Medical Corporation
- Ahmed Shaban🇪🇬Mansoura University Hospital
- Amira Shaban🇪🇬Mansoura University Hospital
- Ali Elkandow🇶🇦Hamad Medical Corporation
- Mohamed Gafar Abdelrahim🇶🇦Hamad Medical Corporation
- Hany A. Zaki🇶🇦Hamad Medical Corporation; Qatar University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
The association between coffee or caffeine intake and cardiovascular diseases (CVDs) and their risk factors has been extensively researched. However, there has been conflicting evidence. Therefore, the current updated meta-analysis assessed the relationship between coffee or caffeine with CVDs, such as coronary heart diseases (CHDs), myocardial infarction (MI), heart failure (HF), stroke, cardiac arrhythmias, and CVD mortality.
Methods
Five electronic databases, namely PubMed, Web of Science, Cochrane Library, Embase, and Scopus, were extensively searched for all records published between January 2000 and December 2025. Studies were included if they examined the effects of coffee on any CVD and reported the associations in terms of the hazard ratio (HR), relative risk (RR), or odds ratio (OR). Moreover, quality appraisal was conducted using the Newcastle Ottawa Scale for cohort studies and the Joanna Briggs Institute tool for case-control studies.
Results
After exclusions, 38 studies involving 2,856,002 participants were reviewed and analyzed. The pooled analysis showed no significant associations between coffee consumption and total CHDs or HF, when comparing the highest and lowest coffee consumption categories (HR: 0.98; p = 0.80 and HR: 1.03; p = 0.62, respectively). In contrast, the pooled results showed a significant positive association between higher coffee consumption and the risk of developing MI (OR: 1.48; p < 0.0001). The pooled analysis also showed an inverse relationship between coffee consumption and stroke or cardiac arrhythmias (HR: 0.89; p = 0.01 and HR: 0.94; p = 0.04, respectively). Furthermore, we observed a non-linear relationship between caffeine intake and CVD mortality among hypertensive patients (HR: 0.68; p = 0.001).
Conclusion
Higher coffee intake might increase the risk of MI, but can also offer protective effects against stroke and cardiac arrhythmias. Moreover, higher caffeine intake can reduce the risk of CVD mortality in hypertensive patients.
Clinical trial registration
PROSPERO: CRD420251073620.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC-ND).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.